The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights
LONDON, Sept 11 (Reuters) - AstraZeneca (AZN.L) appeared to play down speculation about the future of its CEO after its shares fell more than 4% on Monday following a…
This story from reuters.com was posted on 2023-09-11 by @softsky.